A nationwide study, now enrolling in Chicago, is examining whether a drug that is FDA-approved to treat Alzheimer’s disease can prevent the neurodegenerative disease.
“The plaque is not always a sign that you have Alzheimer's. But my understanding is that if you have Alzheimer's, you have the plaque,” Hansen said.
“We are going to give this medication in this group of people to see if we can remove any amyloid that is already there and also prevent any new amyloid from being deposited,” Aggarwal said. “It's a long study, you know, these studies, unfortunately, take long to show results. So it can go up to four years, four and a half years from when people come in,” Aggarwal said.
“I have plaque. And I also have the gene. I got one of the genes, probably from my mom, because she had Alzheimer's, and it raises the likelihood that I will have Alzheimer's,” Hansen said, adding that she believes this is much bigger than her own brain health.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Chicago Med (2015) | ScreenRantChicago Med is a medical drama television series that follows the lives of the doctors and nurses of the fictional Gaffney Chicago Medical Center. Created by Dick Wolf and Matt Olmstead, the show is the third series in Wolf Entertainment's Chicago franchise. Chicago Med premiered on NBC in 2015, and occasionally has crossover events with Chicago Fire and Chicago P.D.
Read more »
Rick Kogan - Chicago TribuneBorn and raised and still living in Chicago, Rick Kogan has worked for the Chicago Daily News, Chicago Sun-Times and the Tribune, where he currently is a columnist. Inducted into the Chicago Journalism Hall of Fame in 2003, he hosts “After Hours with Rick Kogan” on WGN radio and is the author of a dozen books, including “A Chicago Tavern.'
Read more »
Molecule reduces inflammation in Alzheimer's modelsA potential new Alzheimer's drug represses the harmful inflammatory response of the brain's immune cells, reducing disease pathology, preserving neurons and improving cognition in preclinical tests.
Read more »
A High-Tech Headband Could Detect Early Signs of Alzheimer's in Your SleepThere's no cure yet for Alzheimer's, but identifying the risk of developing symptoms as early as possible means that preparations and mitigations can be put in place.
Read more »
Educational attainment protects against a genetic risk factor for Alzheimer's diseaseA new study further illustrates that when it comes to risk of Alzheimer's disease, even genetically determined forms of the disease, genetics is only one piece of the puzzle. Researchers investigated the influence of genetics and educational attainment on cognitive decline by studying data from 675 people who carry a mutation that predisposes them to early onset Alzheimer's disease. Carriers of this mutation -- known as PSEN1 E280A -- have a median age of 49 for onset of dementia. The team found that among carriers who also carried a second mutation that puts them at heightened risk -- APOE e4 -- had an accelerated age of onset of cognitive decline. Among carriers who had an APOE e2 mutation -- known to be protective -- age of onset was delayed. The team also assessed the effect of educational attainment on cognitive function among PSEN1 E280A mutation carriers, including those who carried different APOE genotypes. They found that higher educational attainment -- that is, more years of education -- was associated with preserved cognitive ability particularly for those at highest genetic risk.
Read more »